Suppr超能文献

COVID-19大流行对宫颈癌诊断和管理的影响:罗马尼亚一项基于人群的研究

COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania.

作者信息

Popescu Alin, Craina Marius, Pantea Stelian, Pirvu Catalin, Chiriac Veronica Daniela, Marincu Iosif, Bratosin Felix, Bogdan Iulia, Hosin Samer, Citu Cosmin, Bernad Elena, Neamtu Radu, Dumitru Catalin, Mocanu Adelina Geanina, Avram Claudiu, Gluhovschi Adrian

机构信息

Department of Obstetrics and Gynecology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Department of General Surgery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

出版信息

Diagnostics (Basel). 2022 Apr 6;12(4):907. doi: 10.3390/diagnostics12040907.

Abstract

The Pap test plays a significant role worldwide in the early diagnosis of and high curability rates for cervical cancer. However, the coronavirus disease 2019 (COVID-19) pandemic necessitated the use of multiple drastic measures to stop the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, limiting women's access to essential invasive and non-invasive investigations for cervical cancer diagnosis. Therefore, we aimed to determine the impact the COVID-19 pandemic had on cancer diagnosis and management in western Romania. A retrospective study design allowed us to compare the last 24 months of the pre-pandemic period with the first 24 months of the COVID-19 pandemic to determine the change in volume of cervical screening tests, the number of newly diagnosed cases and their severity, and the access to cancer care. A drastic 75.5% decrease in the volume of tests was observed in April 2020 during the first lockdown, after which the volume of cases decreased by up to 36.1% in December 2021. The total volume loss of tests during the first 24 months of the pandemic was 49.9%. The percentage of late-stage cervical cancers (III-IV) rose by 17%, while the number of newly diagnosed cancers in our outpatient clinic was significantly lower than the baseline, with a 45% drop. The access to cancer care was negatively influenced, with 9.2% more patients waiting longer to receive test results over four weeks, while taking longer to seek cancer care after diagnosis (6.4 months vs. 4.1 months pre-pandemic) and missing significantly more appointments. The COVID-19 pandemic had a significantly negative impact on cervical cancer diagnosis and management during the first 24 months compared with the same period before the pandemic. Although the numbers are now recovering, there is still a big gap, meaning that many cervical cancer cases were potentially missed. We recommend further interventions to reduce the gap between the pre-pandemic and pandemic period.

摘要

巴氏试验在全球宫颈癌的早期诊断和高治愈率方面发挥着重要作用。然而,2019年冠状病毒病(COVID-19)大流行使得必须采取多项严厉措施来阻止严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的传播,这限制了女性获得宫颈癌诊断所需的必要侵入性和非侵入性检查的机会。因此,我们旨在确定COVID-19大流行对罗马尼亚西部癌症诊断和管理的影响。一项回顾性研究设计使我们能够将大流行前最后24个月与COVID-19大流行的前24个月进行比较,以确定宫颈筛查测试量的变化、新诊断病例的数量及其严重程度,以及获得癌症护理的情况。在2020年4月首次封锁期间,测试量急剧下降了75.5%,此后到2021年12月病例量下降了高达36.1%。大流行的前24个月期间测试总量损失了49.9%。晚期宫颈癌(III-IV期)的比例上升了17%,而我们门诊新诊断癌症的数量明显低于基线水平,下降了45%。获得癌症护理受到了负面影响,多9.2%的患者等待四周以上才能收到测试结果,而诊断后寻求癌症护理的时间更长(6.4个月 vs. 大流行前的4.1个月),错过的预约显著增多。与大流行前同期相比,COVID-19大流行在最初24个月对宫颈癌的诊断和管理产生了显著的负面影响。尽管现在数量正在恢复,但仍有很大差距,这意味着许多宫颈癌病例可能被漏诊。我们建议采取进一步干预措施以缩小大流行前和大流行期间的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3680/9031697/378521eb0ba2/diagnostics-12-00907-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验